Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Diabesity drugs and their free ‘contract sales force’
Medical Marketing and Media
Tue, 04/4/23 - 10:12 am
Tags:
Novo Nordisk, Eli Lilly, diabetes, obesity, telehealth, social media, Mounjaro, Wegovy
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CP Wire
Mon, 04/3/23 - 03:35 pm
Tags:
CVS Health, Signify Health, M&A, Ferring Pharmaceuticals, Pfizer, Bristol Myers Squibb, Eli Lilly, Novo Nordisk, Boehringer Ingelheim, Jardiance, Ozempic, drug pricing, Eliquis, CMS
Mon, 04/3/23 - 03:26 pm
Tags:
CVS Health, Signify Health, M&A, Ferring Pharmaceuticals, Pfizer, Bristol Myers Squibb, Eli Lilly, Novo Nordisk, Boehringer Ingelheim, Jardiance, Ozempic, drug pricing, Eliquis, CMS
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
Mon, 04/3/23 - 09:41 am
Tags:
FDA, AbbVie, Alvotech, Ascendis Pharma, Astellas, AstraZeneca, Biogen, Daiichi Sankyo, Eli Lilly, Ferring Pharmaceuticals, Hugel, Innoviva, Ionis Pharmaceuticals, Lundbeck, Merck, Novo Nordisk, Otsuka, Pfizer, Roche Seagen, Seres Therapeutics, Takeda, UCB, Vertex Pharmaceuticals
CHMP gives thumbs-up for Wegovy use in adolescents, along with nine new drug recommendations
Endpoints
Sun, 04/2/23 - 04:17 pm
Tags:
EMA, Europe, CHMP, Wegovy, Novo Nordisk, Bimervax, TG Therapeutics, Eli Lilly, Bristol Myers Squibb, Novartis, AstraZeneca
Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries
Fierce Pharma
Mon, 03/27/23 - 11:23 am
Tags:
Novo Nordisk, Rybelsus, diabetes, clinical trials, Eli Lilly
The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win
Investors Business Daily
Sun, 03/26/23 - 11:28 pm
Tags:
Novo Nordisk, Ozempic, diabetes, obesity
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
CP Wire
Sun, 03/26/23 - 03:44 pm
Tags:
PTC Therapeutics, Novartis, Zolgensma, SMA, Novo Nordisk, Ozempic, obesity, diabetes, Baxter, M&A, Celltrio, Thermo Fisher, Pfizer, Astellas, Xtandi, NIH
Sun, 03/26/23 - 03:36 pm
Tags:
PTC Therapeutics, Novartis, Zolgensma, SMA, Novo Nordisk, Ozempic, obesity, diabetes, Baxter, M&A, Celltrio, Thermo Fisher, Pfizer, Astellas, Xtandi, NIH
In insulin resistance pact, Dewpoint adds Novo Nordisk to its pharma-rich pipeline
Enpoints
Wed, 03/22/23 - 11:13 am
Tags:
Dewpoint Therapeutics, Novo Nordisk, diabetes, insulin resistance, condensates
Six-month Ozempic shortage mostly over after weight-loss craze drained supply
Seattle Times, WA
Mon, 03/20/23 - 04:39 pm
Tags:
Novo Nordisk, drug shortages, Ozempic, diabetes, weight loss
Three's company: Sanofi follows lead of Lilly and Novo, slashes insulin price by 78% and caps out-of-pocket costs
Endpoints
Thu, 03/16/23 - 09:16 pm
Tags:
Sanofi, Lantus, insulin, diabetes, drug pricing, Eli Lilly, Novo Nordisk
Novo Nordisk suspended from ABPI after code breach
Pharmaphorum
Thu, 03/16/23 - 09:30 am
Tags:
Novo Nordisk, ABPI
Strategy Behind Lowered Insulin Prices: Novo Nordisk and Eli Lilly
BioSpace
Wed, 03/15/23 - 10:06 am
Tags:
insulin, diabetes, drug pricing, Eli Lilly, Novo Nordisk
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly
Forbes
Tue, 03/14/23 - 11:27 am
Tags:
Novo Nordisk, drug pricing, insulin, diabetes, Eli Lilly
Covering new weight loss drugs could strain Medicare, policy experts warn
Stat
Sun, 03/12/23 - 09:54 pm
Tags:
obesity, Medicare, Wegovy, Novo Nordisk
Sanders urges Sanofi, Novo Nordisk to be like Eli Lilly in reducing insulin prices
Fierce Pharma
Sun, 03/5/23 - 03:26 pm
Tags:
Eli Lilly, Novo Nordisk, Sanofi, insulin, Bernie Sanders, drug pricing
Big Pharma regained ‘mojo’ last year, but biotech valuations remain ‘precarious’: report
Fierce Biotech
Sun, 03/5/23 - 03:06 pm
Tags:
Big Pharma, Novo Nordisk, Moderna Therapeutics, Gilead Sciences, BeiGene
Novo Nordisk recruits new staff, lays off others as US R&D consolidated in Boston
Fierce Biotech
Thu, 03/2/23 - 10:37 am
Tags:
Novo Nordisk, layoffs, hirings, R&D, Boston
Big-sellers from Merck, Novo and Lilly likely to face Medicare price negotiations: report
Fierce Pharma
Tue, 02/28/23 - 10:39 pm
Tags:
Medicare, drug pricing, Merck, Novo Nordisk, Eli Lilly, Boehringer Ingelheim, JNJ

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.